The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis

INTRODUCTION: Anlotinib, a novel multi-kinase inhibitor, was found to improve progression-free survival (PFS) in brain metastases. METHODS: This paper retrospectively analyzed 26 newly diagnosed or recurrent high-grade gliomas from 2017 to 2022, and the patients received oral anlotinib during concur...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Fangcheng, Li, Jing, Liu, Feng, Sun, Ni, Qiu, XiangNan, Ding, Wei, Sun, XiangDong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982121/
https://www.ncbi.nlm.nih.gov/pubmed/36874124
http://dx.doi.org/10.3389/fonc.2023.1095362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982121/
https://www.ncbi.nlm.nih.gov/pubmed/36874124
http://dx.doi.org/10.3389/fonc.2023.1095362

Ejemplares similares